The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Study identifier: NCT06548256. Status: RECRUITING. Phase: NA.
Eligibility
Criteria: Inclusion Criteria: * Male or female over 20 years old, diagnosed with Parkinson's disease. Exclusion Criteria: * People with Parkinson's disease Dementia, or Lactose Intolerance
- Minimum age: 20 Years
- Maximum age: 90 Years
Participating locations
- Kaohsiung Medical Univeristy Hospital, Kaohsiung City
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.